HIGHLIGHTS
- who: Massimo Dal Monte and colleagues from the Department of Biology, University of Pisa, via San Zeno, , Pisa, Italy have published the paper: Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in Rat Model: Significance for Glaucoma Therapy, in the Journal: (JOURNAL) of February/14,/2019
- what: Significant preclinical gaps need to be bridged before developing therapies that can be used in humans to effectively block glaucoma progression.
SUMMARY
In this respect, the activity of melatonin can be potentiated by the addition of antioxidants among which lipoic_acid is a fatty_acid . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.